Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at atezolizumab for cancers of the urinary tract (AURORA)

Overview

Cancer types:

Bladder cancer, Kidney cancer

Status:

Closed

Details

This trial is open to people with a of the urinary tract. It is for people whose aim of their treatment is to control symptoms ().

The urinary tract includes the:

  • centre of the kidney (renal pelvis)

  • tube that takes urine from the kidney to the bladder (ureter)

  • bladder

  • tube that drains urine from the bladder and out of the body (urethra)

Recruitment start: 30 May 2022

Recruitment end: 31 December 2024

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Simon Crabb

Supported by

Cancer Research UK

Roche

University Hospital Southampton NHS Foundation Trust

Southampton Clinical Trials Unit

National Cancer Research Institute (NCRI)

Last reviewed: 2 January 2025

CRUK internal database number: 18842

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.